The treatment of gonorrhoea--beta lactamase producers

Insights

High rates of penicillin-resistant gonorrhea (PPNG) necessitate replacing penicillin with effective antibiotics like spectinomycin and cephalosporins. Future treatment guidelines must consider impacts on non-PPNG strains and potential syphilis resurgence.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Penicillin resistance in Neisseria gonorrhoeae (PPNG) is a growing global concern.
  • The routine use of procaine penicillin for gonorrhea treatment is becoming increasingly ineffective due to high PPNG endemicity.

Purpose of the Study:

  • To evaluate alternative first-line antibiotic treatments for gonorrhea.
  • To assess the implications of shifting from penicillin to alternative antibiotics for gonorrhea management.

Main Methods:

  • Review of current epidemiological data on PPNG prevalence.
  • Analysis of antibiotic efficacy against Neisseria gonorrhoeae, including PPNG and non-PPNG strains.
  • Consideration of potential public health consequences of treatment guideline changes.

Main Results:

  • Aminoglycosides, spectinomycin, and second/third-generation cephalosporins demonstrate high efficacy against gonorrhea.
  • Shifting treatment away from penicillin may impact non-PPNG strains and could lead to chromosomal resistance.
  • Discontinuation of penicillin may result in an increase in early syphilis cases.

Conclusions:

  • Antibiotics such as spectinomycin and cephalosporins should be considered for first-line gonorrhea treatment due to PPNG.
  • Future treatment recommendations must address potential resistance development and the risk of syphilis resurgence.
  • Further research into synergistic antibiotic combinations, including beta-lactam/beta-lactamase inhibitor combinations, is warranted.

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...